HBCYF

HSBC HOLDINGS PLC

OTC · Savings Institution, Federally Chartered · CIK 0001089113
$17.72 -3.33%
Vol
SEC Reports20

No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

20 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 20 neutral. Avg impact: 2.6/10.
NEUTRAL 6-K 3/10
HSBC Holdings issued A$1.4 billion aggregate in three tranches of senior unsecured notes under its A
Jun 5, 2026
NEUTRAL 6-K 1/10
HSBC Holdings plc filed a routine 6-K providing its total voting rights and capital as of 28 May 202
May 29, 2026
NEUTRAL 6-K 1/10
HSBC Holdings plc filed a Form 6-K notifying the issuance of 3,312 ordinary shares under the HSBC Sh
May 29, 2026
NEUTRAL 6-K 2/10
HSBC filed a routine 6-K reporting the allotment of dividend equivalent shares to PDMRs under the HS
May 27, 2026
NEUTRAL 25-NSE 2/10
HSBC Holdings PLC's 3.900% Senior Unsecured Notes due 2026 were redeemed at maturity on May 25, 2026
May 26, 2026
NEUTRAL 25-NSE 2/10
The NYSE filed a Form 25-NSE to remove from listing and registration HSBC Holdings PLC's 1.589% Fixe
May 26, 2026
NEUTRAL 6-K 2/10
HSBC is hosting the second day of its Asia Seminar for investors and analysts in Hong Kong, featurin
May 21, 2026
NEUTRAL 424B5 4/10
HSBC Holdings is issuing $1.5 billion of 6.750% Perpetual Subordinated Contingent Convertible Securi
May 12, 2026
NEUTRAL 6-K 3/10
HSBC Holdings issued $4.5 billion in senior unsecured notes across two tranches ($2.25B 4.711% notes
May 12, 2026
NEUTRAL 424B5 3/10
HSBC Holdings is issuing $4.5 billion in senior unsecured notes across two tranches ($2.25B 4.711% n
May 8, 2026
NEUTRAL 6-K 2/10
HSBC's 2026 AGM results show all management-proposed resolutions passed with overwhelming support (9
May 8, 2026
NEUTRAL 6-K 4/10
HSBC Holdings plc has issued an amended notice confirming the full redemption of its $2 billion 1.58
Apr 17, 2026
NEUTRAL 6-K 4/10
HSBC Holdings plc is redeeming its entire $2 billion 1.589% Fixed Rate/Floating Rate Senior Unsecure
Apr 16, 2026
NEUTRAL 6-K 3/10
HSBC disclosed that David Lindberg, Chief Executive of HSBC UK Bank plc, received a total of 1,034,6
Apr 2, 2026
NEUTRAL 6-K 2/10
HSBC granted conditional awards for 2,119,724 ordinary shares to employees and former employees unde
Apr 2, 2026
NEUTRAL 6-K 2/10
HSBC Holdings plc filed a routine 6-K to disclose its total voting rights as of March 27, 2026, repo
Mar 30, 2026
NEUTRAL 6-K 3/10
HSBC issued 8,306,497 new Ordinary Shares under its HSBC Share Plan 2011 during March 2026, increasi
Mar 30, 2026
NEUTRAL 6-K 4/10
HSBC Holdings plc published a base prospectus dated March 30, 2026, for its Debt Issuance Programme,
Mar 30, 2026
NEUTRAL 6-K 3/10
HSBC Holdings plc issued $130 million in 5.48% fixed-rate senior unsecured notes due 2036 under its
Mar 27, 2026
NEUTRAL 6-K 2/10
HSBC Holdings plc has announced the details of its 2026 Annual General Meeting (AGM), including the
Mar 27, 2026

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution: 52% buy across 21 analysts — 3 strong buy, 8 buy, 8 hold, 2 sell, 0 strong sell. No current recommendation available.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
2026-06-30
$0.00 $0.00 $0.00 $18.9B 6.9%
Next Q
2026-09-30
$0.00 $0.00 $0.00 $19.2B 7.1%
Current FY
2026-12-31
$0.00 $0.00 $0.00 $74.8B 5.4%
Next FY
2027-12-31
$0.00 $0.00 $0.00 $77.9B 4.1%

Monthly Consensus History

PeriodStrong BuyBuyHoldSellStrong SellBuy %Distribution
Jun 1, 20263882052%
May 1, 20263982055%
Apr 1, 20263982055%
Mar 1, 20263882052%
Feb 1, 202637101048%
Jan 1, 20263790053%
Strong BuyBuyHoldSellStrong Sell

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.